• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Cognition Therapeutics Inc (NQ: CGTX )

    1.940 +0.020 (+1.04%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 18, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 57,241
    Open 1.930
    Bid (Size) 2.080 (1)
    Ask (Size) 2.100 (1)
    Prev. Close 1.920
    Today's Range 1.920 - 1.980
    52wk Range 0.9001 - 2.950
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Results from Cognition Therapeutics’ Phase 2 SHINE Study of CT1812 in Mild-to-Moderate Alzheimer’s Disease Accepted for Presentation at AAIC
    From Cognition Therapeutics, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga

    Performance

    YTD
    N/A
    N/A
    1 Month
    -11.42%
    -11.42%
    3 Month
    +2.11%
    +2.11%
    6 Month
    -18.83%
    -18.83%
    1 Year
    +9.60%
    +9.60%

    More News

    Read More
    Cognition Therapeutics Releases New Episode of “Conversations” Podcast: Protecting the Synapse from Amyloid Toxicity in Alzheimer's Disease
    From Cognition Therapeutics, Inc.
    Via GlobeNewswire
    A Preview Of Cognition Therapeutics's Earnings
    Via Benzinga
    CGTX Stock Earnings: Cognition Therapeutics Beats EPS for Q1 2024
    Via InvestorPlace
    Cognition Therapeutics Reports Financial Results for the First Quarter 2024 and Provides Business Update
    From Cognition Therapeutics, Inc.
    Via GlobeNewswire
    Cognition Therapeutics Completes Enrollment in Phase 2 SHIMMER Study of CT1812 in Mild-to-Moderate Dementia with Lewy Bodies
    From Cognition Therapeutics, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Cognition Therapeutics KOL Event Provided Platform for Valuable Discussion of Current Therapeutic Options and Need for Additional Options to Treat Alzheimer’s Disease
    From Cognition Therapeutics, Inc.
    Via GlobeNewswire
    Cognition Therapeutics to Present at the Needham Virtual Healthcare Conference
    From Cognition Therapeutics, Inc.
    Via GlobeNewswire
    Cognition Therapeutics to host Virtual KOL Event on the Evolving Landscape in Alzheimer’s Disease on April 12, 2024
    From Cognition Therapeutics, Inc.
    Via GlobeNewswire
    CGTX Stock Earnings: Cognition Therapeutics Beats EPS for Q4 2023
    Via InvestorPlace
    Cognition Therapeutics Reports Year End 2023 Financial Results and Provides Business Update
    From Cognition Therapeutics, Inc.
    Via GlobeNewswire
    BioMedNewsBreaks – Cognition Therapeutics Inc. (NASDAQ: CGTX) Closes on $11.5M Public Offering
    Via Investor Brand Network
    Earnings Scheduled For March 26, 2024
    Via Benzinga
    Cognition Therapeutics to Report Fourth Quarter and Full Year 2023 Results
    From Cognition Therapeutics, Inc.
    Via GlobeNewswire
    Cognition Therapeutics And 2 Other Stocks Under $2 Insiders Are Buying
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Cognition Therapeutics Announces Closing of $11.5 Million Public Offering of Common Stock
    From Cognition Therapeutics, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Cognition Therapeutics Announces Proposed Public Offering of Common Stock
    From Cognition Therapeutics, Inc.
    Via GlobeNewswire
    Cognition Therapeutics Presents Analyses at AD/PD™ 2024 Correlating Proteomic Findings with Treatment Effect of CT1812 in Alzheimer’s Disease Studies
    From Cognition Therapeutics, Inc.
    Via GlobeNewswire
    Cognition Therapeutics to Present at the TD Cowen Health Care Conference
    From Cognition Therapeutics, Inc.
    Via GlobeNewswire
    New Publication Identifies Key Proteins Involved in Amyloid Oligomer Binding and Supports Mechanism of CT1812
    From Cognition Therapeutics, Inc.
    Via GlobeNewswire
    Why Airspan Networks Shares Are Trading Higher By Over 380%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.